Difference between revisions of "Team:SYSU-MEDICINE"

 
(One intermediate revision by the same user not shown)
Line 565: Line 565:
 
             <div class="left">
 
             <div class="left">
 
                 <h1>MSCavalry</h1>
 
                 <h1>MSCavalry</h1>
−
                 <h3>-----MSCs of<br/>next generation</h3>
+
                 <h3>-----MSCs of<br/>Next Generation</h3>
 
             </div>
 
             </div>
 
             <div class="right">
 
             <div class="right">
Line 574: Line 574:
 
                 </p>
 
                 </p>
 
                 <p>
 
                 <p>
−
                     This year, MSCavalry: MSCs of next generation is coming.
+
                     This year, MSCavalry: MSCs of Next Generation is coming.
−
                     SYSU-MEDICINE decide to engineer a set of MSCs (homo sapiens) with higher accuracy and we hope that our project can pave the way for future MSCs clinical application.
+
                     SYSU-MEDICINE decided to engineer a set of MSCs (homo sapiens) with higher accuracy and we hope that our project can pave the way for future MSCs clinical application.
 
                 </p>
 
                 </p>
 
             </div>
 
             </div>
Line 618: Line 618:
 
             <div class="my-card" id="card-6">
 
             <div class="my-card" id="card-6">
 
                 <img src="https://static.igem.org/mediawiki/2016/d/d6/T--SYSU-MEDICINE--home-Card6.png">
 
                 <img src="https://static.igem.org/mediawiki/2016/d/d6/T--SYSU-MEDICINE--home-Card6.png">
−
                 <span class="card-text"><a href="#">Click to go to the details page ></a></span>
+
                 <span class="card-text"><a href=" https://2016.igem.org/Team:SYSU-MEDICINE/Description">Click to go to the details page ></a></span>
 
             </div>
 
             </div>
 
         </div>
 
         </div>

Latest revision as of 02:56, 20 October 2016

MSCavalry

-----MSCs of
Next Generation

Inflammatory diseases are an increasing cause of disability and even fatality. Currently, apart from common treatments, MSCs therapy is a promising candidate for curing inflammatory diseases. However, intravascular injected MSCs are criticized for its low homing efficiency and ambiguous distribution in human body.

This year, MSCavalry: MSCs of Next Generation is coming. SYSU-MEDICINE decided to engineer a set of MSCs (homo sapiens) with higher accuracy and we hope that our project can pave the way for future MSCs clinical application.